HIPRA is a biotech pharmaceutical company headquartered in Amer, Catalonia, Spain focused on prevention for animal and human health, with a product base...
5 KB (497 words) - 14:19, 2 April 2024
used for wild rabbit control in Australia. CUNIPRAVAC RHD, manufactured by HIPRA, protects against the RHDVa strains found in Europe. Nobivac Myxo-RHD, made...
45 KB (4,795 words) - 15:38, 11 March 2024
on 19 July 2021. Retrieved 7 September 2021. Barrie R (31 March 2023). "Hipra's Covid-19 booster gets EMA nod and enters an uncertain landscape". Pharmaceutical...
199 KB (22,726 words) - 08:47, 6 August 2024
VidPrevtyn Beta 10 November 2022 12 December 2022 Bimervax (COVID-19 Vaccine HIPRA) 30 March 2023 Pending CoronaVac Pending No but recognition on 31 March...
60 KB (2,698 words) - 12:24, 27 July 2024
the Philippines (phase II), South Korea (phase I/II) Preclinical PHH-1V Hipra Spain Subunit Phase I–II (286) Phase I/IIa (30): Randomized, controlled...
95 KB (18,965 words) - 15:46, 23 June 2024